100% Use of Infection Control Procedures in Hemodialysis Facilities

Vijayan, Anitha; Boyce, John M.

doi:10.2215/cjn.11341017

Cited by 15 publications

(11 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…12 In addition to bacterial infections, ESKD patients undergoing MHD are also susceptible to viral infections like hepatitis B virus, hepatitis C virus, HIV, and influenza. 13 A major outbreak of SARS that affecting .300 patients in Hong Kong was triggered by a patient on dialysis. It has been speculated that a patient having renal failure might carry an extraordinarily high viral load of SARS, which could lead to a large outbreak.…”

Section: Discussionmentioning

confidence: 99%

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China

Xiong

Tang

Liu

et al. 2020

JASN

251

284

View full text Add to dashboard Cite

BackgroundReports indicate that those most vulnerable to developing severe coronavirus disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as diabetes mellitus, hypertension, or cardiovascular disease, which are common comorbidities among patients undergoing maintenance hemodialysis. However, there is limited information about the clinical characteristics of hemodialysis patients with COVID-19 or about interventions to control COVID-19 in hemodialysis centers.MethodsWe collected data retrospectively through an online registration system that includes all patients receiving maintenance hemodialysis at 65 centers in Wuhan, China. We reviewed epidemiologic and clinical data of patients with laboratory-confirmed COVID-19 between January 1, 2020 and March 10, 2020.ResultsOf 7154 patients undergoing hemodialysis, 154 had laboratory-confirmed COVID-19. The mean age of the 131 patients in our analysis was 63.2 years; 57.3% were men. Many had underlying comorbidities, with cardiovascular disease (including hypertension) being the most common (68.7%). Only 51.9% of patients manifested fever; 21.4% of infected patients were asymptomatic. The most common finding on chest computed tomography (CT) was ground-grass or patchy opacity (82.1%). After initiating comprehensive interventions—including entrance screening of body temperature and symptoms, universal chest CT and blood tests, and other measures—new patients presenting with COVID-19 peaked at 10 per day on January 30, decreasing to 4 per day on February 11. No new cases occurred between February 26 and March 10, 2020.ConclusionsWe found that patients receiving maintenance hemodialysis were susceptible to COVID-19 and that hemodialysis centers were high-risk settings during the epidemic. Increasing prevention efforts, instituting universal screening, and isolating patients with COVID-19 and directing them to designated hemodialysis centers were effective in preventing the spread of COVID-19 in hemodialysis centers.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China

Xiong

Tang

Liu

et al. 2020

JASN

251

284

View full text Add to dashboard Cite

show abstract

“…Renal insu ciency leads to immunode ciency and increased susceptibility to infection 10,11 . Patients are regularly treated in dialysis centers in a coherent manner three times weekly while they are in a nonmedical and therefore not hygienically controllable environment between treatments.…”

Section: Discussionmentioning

confidence: 99%

Impact of the SARS-CoV-2 Pandemic on the Treatment and Care of Patients With Chronic Kidney Disease in Germany: Results of a Nationwide Survey

Walendy

Girndt

Greinert

2020

Preprint

View full text Add to dashboard Cite

Impact of the SARS-CoV-2 pandemic on the treatment and care of patients with chronic kidney disease in Germany: Results of a nationwide survey Background/Aims The SARS-CoV-2 pandemic is a major challenge for patients, healthcare professionals and populations worldwide. Many peculiarities arise in dealing with outpatient and inpatient dialysis patients, patients with chronic kidney disease, or kidney transplantation. We conducted this first nationwide survey in German dialysis facilities to map the situation in May 2020, to explore the feasibility of the hygiene recommendations, and to identify changes in non-dialysis CKD-patient treatment. Methods A cross-sectional voluntary online questionnaire survey with 65 items was distributed by email using the mailing list of the DGfN as the scientific association for Nephrology, the “Verband Deutscher Nierenzentren (DN)” as the association of German dialysis facilities in private practice, and the “Kuratorium für Dialyse und Nierentransplantation (KfH)”, the largest non-profit dialysis service provider in Germany. The target population was nephrologists in dialysis facilities. 382 participants took part in the survey. Results The majority of centers were able to treat SARS-CoV-2- infected dialysis patients or had agreements with other centers to transfer these patients. Until mid-May 42% already treated SARS-CoV-2 infected dialysis Patients. Compliance with the hygiene recommendations is considered high among employees and patients. Nevertheless 18% of the facilities reported infected staff, which in 55% of the cases were presumably work-related. Changes in the area of deployment of employees who belong to the risk group pressurize personnel situation in the dialysis facilities, as well as sickness-related absences or quarantine orders by the health authorities. Perspectively a majority expects economic losses (82%), shortage of safety equipment (53%) and staff (74%), respectively. Conclusion The SARS-CoV-2 pandemic had a significant impact on the care of patients with chronic kidney disease, but there were no obvious deficits in care. This is probably due to the high degree of cooperation among dialysis provider and comprehensive recommendations of nephrologists societies.

show abstract

“…To reach this goal, NTDS uses a multi-pronged approach. For example, education strategies via publications 139 – 143 and webinars that address various aspects of infection prevention and standards of care, use of social media, development of an interactive chapter for trainees and clinicians, and invited lectures are aimed at ensuring that nephrologists, nurses, dialysis administrators and other professionals understand the risk of dialysis-related infections and evidence-based best working practices.…”

Section: Fostering Innovationmentioning

confidence: 99%

The current and future landscape of dialysis

Vanholder²,

et al. 2020

View full text Add to dashboard Cite

The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set in motion several dramatic changes in the epidemiology, economics and ethical frameworks for the treatment of kidney failure. However, despite a rapid expansion in the provision of dialysis — particularly haemodialysis and most notably in high-income countries (HICs) — the rate of true patient-centred innovation has slowed. Current trends are particularly concerning from a global perspective: current costs are not sustainable, even for HICs, and globally, most people who develop kidney failure forego treatment, resulting in millions of deaths every year. Thus, there is an urgent need to develop new approaches and dialysis modalities that are cost-effective, accessible and offer improved patient outcomes. Nephrology researchers are increasingly engaging with patients to determine their priorities for meaningful outcomes that should be used to measure progress. The overarching message from this engagement is that while patients value longevity, reducing symptom burden and achieving maximal functional and social rehabilitation are prioritized more highly. In response, patients, payors, regulators and health-care systems are increasingly demanding improved value, which can only come about through true patient-centred innovation that supports high-quality, high-value care. Substantial efforts are now underway to support requisite transformative changes. These efforts need to be catalysed, promoted and fostered through international collaboration and harmonization.

show abstract

100% Use of Infection Control Procedures in Hemodialysis Facilities

Cited by 15 publications

References 5 publications

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China

Impact of the SARS-CoV-2 Pandemic on the Treatment and Care of Patients With Chronic Kidney Disease in Germany: Results of a Nationwide Survey

The current and future landscape of dialysis

Contact Info

Product

Resources

About